Psychemedics Total Current Liabilities 2010-2024 | PMD
Psychemedics total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Psychemedics Annual Total Current Liabilities
(Millions of US $) |
| 2023 |
$5 |
| 2022 |
$6 |
| 2021 |
$6 |
| 2020 |
$4 |
| 2019 |
$6 |
| 2018 |
$4 |
| 2017 |
$4 |
| 2016 |
$4 |
| 2015 |
$4 |
| 2014 |
$4 |
| 2013 |
$3 |
| 2012 |
$2 |
| 2011 |
$2 |
| 2010 |
$2 |
| 2009 |
$1 |
Psychemedics Quarterly Total Current Liabilities
(Millions of US $) |
| 2024-09-30 |
$4 |
| 2024-06-30 |
$4 |
| 2024-03-31 |
$4 |
| 2023-12-31 |
$5 |
| 2023-09-30 |
$5 |
| 2023-06-30 |
$6 |
| 2023-03-31 |
$6 |
| 2022-12-31 |
$6 |
| 2022-09-30 |
$6 |
| 2022-06-30 |
$5 |
| 2022-03-31 |
$5 |
| 2021-12-31 |
$6 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$4 |
| 2020-12-31 |
$4 |
| 2020-09-30 |
$3 |
| 2020-06-30 |
$3 |
| 2020-03-31 |
$5 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$5 |
| 2019-06-30 |
$4 |
| 2019-03-31 |
$4 |
| 2018-12-31 |
$4 |
| 2018-09-30 |
$6 |
| 2018-06-30 |
$5 |
| 2018-03-31 |
$5 |
| 2017-12-31 |
$4 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$3 |
| 2017-03-31 |
$5 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$5 |
| 2016-06-30 |
$5 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$4 |
| 2015-09-30 |
$4 |
| 2015-06-30 |
$4 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$4 |
| 2014-09-30 |
$4 |
| 2014-06-30 |
$4 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$3 |
| 2013-09-30 |
$2 |
| 2013-06-30 |
$2 |
| 2013-03-31 |
$2 |
| 2012-12-31 |
$2 |
| 2012-09-30 |
$2 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$2 |
| 2011-06-30 |
$2 |
| 2011-03-31 |
$2 |
| 2010-12-31 |
$2 |
| 2010-09-30 |
$2 |
| 2010-06-30 |
$1 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.014B |
$0.022B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
